Matthew Maxwell Donley, COO: Aurinia Pharmaceuticals AUPH Planned sale · Filed 05/11

Trade details

Type: Planned sale notice
Stock: Aurinia Pharmaceuticals AUPH
Person: Matthew Maxwell DonleyCOO
Planned sale date: 26/05/11
Filed: 26/05/11

0.6% of shares outstanding to be sold

Aurinia Pharmaceuticals trades, last 26 weeks

What else happened in Aurinia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 04/11~06/10

Matthew Maxwell Donley's recent trades

Matthew Maxwell DonleyCOO
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$527.2K
65,902 sh
$527.2K
Filed 25/03/04
Traded 25/03/03
Matthew Maxwell DonleyCOO
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$467.2K
58,991 sh
$467.2K
Filed 25/03/04
Traded 25/03/04
Matthew Maxwell DonleyEVP, Ops & Strategy
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$224.1K
40,665 sh
$224.1K
Filed 24/03/07
Traded 24/03/06

Matthew Maxwell Donley, COO — plans to sell 717,688 sh of Aurinia Pharmaceuticals AUPH · $11.4M · around 05/11 | Whalegun